CD38 and thoracic cancer: Given the significant roles played by both T-bet and CD38 in immunosenescence, our data provide insights into the cellular and molecular mechanisms linking RT-induced p90RSK activation, immunosenescence, T-bet, and CD38 induction observed in thoracic cancer patients undergoing RT.